World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
81
Citations
20655
World Ranking
1586
National Ranking
790

Doina Ganea publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Doina Ganea sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 223 publications — 42nd percentile

42% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Doina Ganea D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Doina Ganea sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 81 D-Index — 69th percentile

69% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Doina Ganea is affiliated with Temple University in the United States and works primarily in the field of Medicine. Their research focuses on oncology and hepatology, with particular attention to hepatocellular carcinoma treatment and prognosis, peptidase inhibition and analysis, as well as pancreatic and hepatic oncology research.

They have contributed to the scientific literature with publications mainly appearing in the journal Cancers. One notable paper authored by Doina Ganea is titled Namodenoson in Advanced Hepatocellular Carcinoma and Child-Pugh B Cirrhosis: Randomized Placebo-Controlled Clinical Trial, published in 2021 in Cancers.

Their collaboration network includes frequent co-authors such as:

  • Salomon M. Stemmer
  • Nebojša Manojlović
  • Mihai Vasile Marinca
  • Petar Petrov
  • Nelly Cherciu

Doina Ganea's research contributions reflect a consistent engagement with the following topics:

  • Hepatocellular Carcinoma Treatment and Prognosis
  • Peptidase Inhibition and Analysis
  • Pancreatic and Hepatic Oncology Research

Their academic work is situated across the following research areas:

  • Medicine
  • Oncology
  • Hepatology

Best Publications

  • Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

    Tony S.K. Mok;Yi Long Wu;Iveta Kudaba;Dariusz M. Kowalski

  • Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial

    Luis Paz-Ares;Mikhail Dvorkin;Yuanbin Chen;Niels Reinmuth

  • The Significance of Vasoactive Intestinal Peptide in Immunomodulation

    Mario Delgado;David Pozo;Doina Ganea

  • Phase III Trial of Ipilimumab Combined With Paclitaxel and Carboplatin in Advanced Squamous Non–Small-Cell Lung Cancer

    Ramaswamy Govindan;Aleksandra Szczesna;Myung Ju Ahn;Claus Peter Schneider

  • The Proinflammatory Effect of Prostaglandin E2 in Experimental Inflammatory Bowel Disease Is Mediated through the IL-23→IL-17 Axis

    Amir F. Sheibanie;Jui-Hung Yen;Jui-Hung Yen;Tanzilya Khayrullina;Tanzilya Khayrullina;Frances Emig

  • Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase-activating Polypeptide Inhibit Tumor Necrosis Factor α Transcriptional Activation by Regulating Nuclear Factor-kB and cAMP Response Element-binding Protein/c-Jun

    Mario Delgado;Ernesto J. Munoz-Elias;Yanqing Kan;Illana Gozes

  • Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-kappa B and IFN regulatory factor 1 activation.

    Mario Delgado;Ernesto J. Munoz-Elias;Rosa P. Gomariz;Doina Ganea

  • Cecal Ligation Puncture Procedure

    Miguel G. Toscano;Doina Ganea;Ana M. Gamero

  • Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase-Activating Polypeptide Enhance IL-10 Production by Murine Macrophages: In Vitro and In Vivo Studies

    Mario Delgado;Ernesto J. Munoz-Elias;Rosa P. Gomariz;Doina Ganea

  • Vasoactive Intestinal Peptide (VIP) and Pituitary Adenylate Cyclase-Activation Polypeptide (PACAP) Protect Mice from Lethal Endotoxemia Through the Inhibition of TNF-α and IL-6

    Mario Delgado;Mario Delgado;Carmen Martinez;David Pozo;Juan R. Calvo

  • Vasoactive intestinal peptide: a neuropeptide with pleiotropic immune functions.

    Mario Delgado;Doina Ganea

  • Vasoactive intestinal peptide generates human tolerogenic dendritic cells that induce CD4 and CD8 regulatory T cells

    Elena Gonzalez-Rey;Alejo Chorny;Alejo Chorny;Amelia Fernandez-Martin;Amelia Fernandez-Martin;Doina Ganea;Doina Ganea

  • Prostaglandin E2 induces IL-23 production in bone marrow-derived dendritic cells

    Amir F. Sheibanie;Iman Tadmori;Huie Jing;Evros Vassiliou

  • Neuroprotective effect of vasoactive intestinal peptide (VIP) in a mouse model of Parkinson's disease by blocking microglial activation.

    Mario Delgado;Doina Ganea

  • VIP and PACAP inhibit IL-12 production in LPS-stimulated macrophages. Subsequent effect on IFNγ synthesis by T cells

    Mario Delgado;Mario Delgado;Ernesto J Munoz-Elias;Rosa P Gomariz;Doina Ganea

  • Vasoactive intestinal peptide induces regulatory dendritic cells with therapeutic effects on autoimmune disorders

    Alejo Chorny;Elena Gonzalez-Rey;Amelia Fernandez-Martin;David Pozo

  • In vitro differentiation of dendritic cells in the presence of prostaglandin E2 alters the IL-12/IL-23 balance and promotes differentiation of Th17 cells.

    Tanzilya Khayrullina;Jui-Hung Yen;Huie Jing;Doina Ganea

  • Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit endotoxin-induced TNF-alpha production by macrophages: in vitro and in vivo studies.

    Mario Delgado;Mario Delgado;David Pozo;Carmen Martinez;Javier Leceta

  • PGE2-induced metalloproteinase-9 is essential for dendritic cell migration

    Jui-Hung Yen;Tanzilya Khayrullina;Tanzilya Khayrullina;Doina Ganea

  • Prostaglandin E2 exacerbates collagen-induced arthritis in mice through the inflammatory interleukin-23/interleukin-17 axis.

    Amir F. Sheibanie;Tanzilya Khayrullina;Fayez F. Safadi;Doina Ganea

  • Vasoactive Intestinal Peptide and Pituitary Adenylyl Cyclase-Activating Polypeptide Inhibit Tumor Necrosis Factor-α Production in Injured Spinal Cord and in Activated Microglia via a cAMP-Dependent Pathway

    Woong-Ki Kim;Yanqing Kan;Doina Ganea;Ronald P. Hart

  • Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit chemokine production in activated microglia.

    Mario Delgado;Mario Delgado;G. Miller Jonakait;G. Miller Jonakait;Doina Ganea

  • Vasoactive Intestinal Peptide (VIP) and Pituitary Adenylate Cyclase-activating Polypeptide (PACAP) as Modulators of Both Innate and Adaptive Immunity

    Doina Ganea;Mario Delgado

Frequent Co-Authors

Mario Delgado
Mario Delgado Spanish National Research Council
Elena Gonzalez-Rey
Elena Gonzalez-Rey Spanish National Research Council
Rosa P. Gomariz
Rosa P. Gomariz Complutense University of Madrid
Javier Leceta
Javier Leceta Complutense University of Madrid
Carmen Martinez Mora
Carmen Martinez Mora Complutense University of Madrid
Juan R. Calvo
Juan R. Calvo University of Seville
Raj K. Razdan
Raj K. Razdan Organix (United States)
Ronald P. Hart
Ronald P. Hart Rutgers, The State University of New Jersey
Illana Gozes
Illana Gozes Tel Aviv University
Billy R. Martin
Billy R. Martin Virginia Commonwealth University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can open diverse career opportunities. Many students begin their journey with accessible programs like easy admission LPN programs, offering a solid foundation in patient care and clinical skills. These programs often serve as stepping stones toward more advanced nursing roles.

Nurses aiming to specialize further may consider pursuing a Family Nurse Practitioner license through some of the easiest FNP programs, which balance rigorous training with achievable admission requirements. This pathway is ideal for those seeking both clinical practice and patient management experience aligned with immunological health.

Mental health is another vital area where immunology insights are increasingly relevant. The top PMHNP programs provide excellent clinical placements, ensuring practical experience in psychiatric nursing that complements immunological research and care.

For budget-conscious students, finding cheap psych NP programs can make advanced nursing education more accessible without sacrificing quality. These affordable options help cultivate specialized knowledge useful in immunology-related mental health fields.

Choosing the right online degree program is crucial for building a sustainable career connected to immunology, with each of these pathways offering unique advantages depending on your professional goals.

Best Scientists Citing Doina Ganea

Trending Scientists

Recently Published Articles